跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA FRESENIUS KABI 10 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA FRESENIUS KABI 10 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA FRESENIUS KABI 10 MG CAPSULAS DURAS EFG
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 26, 2021
Approval ID
af0805c58e59dfbc
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
af0805c58e59dfbc
Drug Cima Aemps Name
LENALIDOMIDA FRESENIUS KABI 10 MG CAPSULAS DURAS EFG
Register Number
86096
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2021-07-26
Dosage Form
CÁPSULA DURA
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
LENALIDOMIDA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 26, 2021
Approval ID
af0805c58e59dfbc
Type
Standard
Back to CIMA-AEMPS Approvals
